STAR COMBO PHARMA LIMITED CORPORATE GOVERNANCE STATEMENT – 2026 Principle 1 – Lay Solid Foundations for Management and Oversight 1.1 A listed entity should disclose: See separate disclosures under Board Charter (a) The respective roles and responsibilities of its board and management; and (b)...
S66 2026 Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Star Combo Pharma
- S66 2026 AGM - NOM / EM / Proxy
- S66 2026 Annual Report
- S66 Date of 2026 AGM
- Dividend/Distribution - S66
- S66 Preliminary Final Report & Full Year Statutory Accounts
Later from Star Combo Pharma
All Star Combo Pharma news releasesFollow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma